Showing results (1131-1140 of 4,992) with videos related to
Sort By:
Pageof 500
Headache|November 25, 2025
Engagement and predictors of use of a smartphone app for migraine self-management: A secondary analysis of the EMMA trialStefanie Lysk, Daniel Pach, Tatjana Tissen-Diabaté, et al.Headache|November 13, 2025
Quality of life changes in cluster headache: Convergent validity, responsiveness, and interpretability of the Cluster Headache Quality of Life scale as a patient-reported outcome measureWillemijn C Naber, Paulien J van Tilborg, Roemer B Brandt, et al.Headache|November 22, 2025
Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double-blind, randomized, controlled trial (PAREMA1)Charly Gaul, Sónia Ferreira, Troels JohansenHeadache|December 15, 2025
Amplifying and ameliorating light avoidance in mice with photoreceptor targeting and calcitonin gene-related peptide sensitizationEric A Kaiser, Audrey Cavanah, Geoffrey K Aguirre, et al.Headache|November 7, 2025
Intravenous magnesium and methocarbamol for acute pain crises in refractory trigeminal neuralgia: A retrospective analysisBradley Ong, Victor Lomachinsky-Torres, Nymisha Mandava, et al.Headache|July 7, 2025
A retrospective cohort study to evaluate the effectiveness and safety profile of occipital nerve blocks in the treatment of migraine during pregnancyLiza Smirnoff, Leon Moskatel, Blake Shaw, et al.Headache|July 15, 2025
Headache Assessment via Digital Platform in United States: Baseline study characteristics, diagnosis, and treatment patternsAli Ezzati, Kristina M Fanning, Devin Teichrow, et al.Headache|July 15, 2025
Real-world barriers to health care utilization among people living with migraine: Insights from the All of Us Research ProgramIdris Demirsoy, Richard B Lipton, Ali EzzatiHeadache|October 14, 2025
How much aerobic exercise is needed to reduce migraine? A dose-response meta-analysis of pain intensity and frequencyDaniel C Ogrezeanu, Rodrigo Núñez-Cortés, Joaquín Salazar-Méndez, et al.Headache|October 14, 2025
Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE studyGabriel Paiva da Silva Lima, Renata Rao, Gyöngyi Szabó, et al.Pageof 500